The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1169-1177.e16, December 2008

Hypomorphic nuclear factor-κB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity

  • Eric P. Hanson, MD

      Affiliations

    • Division of Rheumatology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Linda Monaco-Shawver, BA

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Laura A. Solt, BS

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Lisa A. Madge, PhD

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Pinaki P. Banerjee, PhD

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
  • ,
  • Michael J. May, PhD

      Affiliations

    • Department of Animal Biology, University of Pennsylvania School of Veterinary Medicine, Philadelphia, Pa
  • ,
  • Jordan S. Orange, MD, PhD

      Affiliations

    • Division of Allergy and Immunology, Joseph Stokes Jr Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pa
    • Corresponding Author InformationReprint requests: Jordan S. Orange, MD, PhD, Children's Hospital of Philadelphia, Abramson Research Center 1016H, 3615 Civic Center Boulevard, Philadelphia, PA 19104.

Received 30 June 2008; received in revised form 18 August 2008; accepted 20 August 2008. published online 13 October 2008.

Background

Human hypomorphic nuclear factor-κB essential modulator (NEMO) mutations cause diverse clinical and immunologic phenotypes, but understanding of their scope and mechanistic links to immune function and genotype is incomplete.

Objective

We created and analyzed a database of hypomorphic NEMO mutations to determine the spectrum of phenotypes and their associated genotypes and sought to establish a standardized NEMO reconstitution system to obtain mechanistic insights.

Methods

Phenotypes of 72 individuals with NEMO mutations were compiled. NEMO L153R and C417R were investigated further in a reconstitution system. TNF-α or Toll-like receptor (TLR)–5 signals were evaluated for nuclear factor-κB activation, programmed cell death, and A20 gene expression.

Results

Thirty-two different mutations were identified; 53% affect the zinc finger domain. Seventy-seven percent were associated with ectodermal dysplasia, 86% with serious pyogenic infection, 39% with mycobacterial infection, 19% with serious viral infection, and 23% with inflammatory diseases. Thirty-six percent of individuals died at a mean age of 6.4 years. CD40, IL-1, TNF-α, TLR, and T-cell receptor signals were impaired in 15 of 16 (94%), 6 of 7 (86%), 9 of 11 (82%), 9 of 14 (64%), and 7 of 18 (39%), respectively. Hypomorphism-reconstituted NEMO-deficient cells demonstrated partial restoration of NEMO functions. Although both L153R and C417R impaired TLR and TNF-α–induced NF-κB activation, L153R also increased TNF-α–induced programmed cell death with decreased A20 expression.

Conclusion

Distinct NEMO hypomorphs define specific disease and genetic characteristics. A reconstitution system can identify attributes of hypomorphisms independent of an individual's genetic background. Apoptosis susceptibility in L153R reconstituted cells defines a specific phenotype of this mutation that likely contributes to the excessive inflammation with which it is clinically associated.

Key words: NEMO, immunodeficiency, genetic database, Jurkat reconstitution, NF-κB activation, A20

Abbreviations used: 7-AAD, 7-Amino actinomycin D, DC, Dendritic cell, EDA, Ectodermal dysplasia and anhidrosis, EMSA, Electrophoretic mobility shift assay, FACS, Fluorescence-activated cell sorting, GFP, Green fluorescent protein, IKK, IκB kinase, NEMO, Nuclear factor-κB essential modulator, NF-κB, Nuclear factor-κB, pNEMO, Parental nuclear factor-κB essential modulator, rNEMO, Wild-type reconstituted NEMO(-), TCR, T-cell receptor

 

 Supported by National Institutes of Health (NIH) AI079731 (J.S.O.), US Immunodeficiency Network Grant NIH N01 AI-22070 (J.S.O., M.J.M.), NIH HL080612 (M.J.M), the Pennsylvania Department of Health (J.S.O.; the Pennsylvania Department of Health specifically disclaims responsibility for any analyses, interpretations, or conclusions from this study), a career development award from the American Academy of Allergy, Asthma & Immunology (J.S.O.), NIH 5T32CA009140-33 (E.P.H.), and the Penn Center for Clinical Immunology Jackson-Wade Fellowship (E.P.H.)

 Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.

PII: S0091-6749(08)01545-5

doi:10.1016/j.jaci.2008.08.018

The Journal of Allergy and Clinical Immunology
Volume 122, Issue 6 , Pages 1169-1177.e16, December 2008